Paratek Pharmaceuticals, Inc. EBITDA 2010-2023 | PRTK
Paratek Pharmaceuticals, Inc. ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Paratek Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-46 |
| 2021 | $-41 |
| 2020 | $-75 |
| 2019 | $-117 |
| 2018 | $-105 |
| 2017 | $-83 |
| 2016 | $-107 |
| 2015 | $-69 |
| 2014 | $-8 |
| 2013 | $-7 |
| 2012 | $-11 |
| 2011 | $-2 |
| 2010 | $-8 |
| 2009 | $-20 |
| Paratek Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-06-30 | $-9 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-3 |
| 2022-09-30 | $-16 |
| 2022-06-30 | $-13 |
| 2022-03-31 | $-14 |
| 2021-12-31 | $-27 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $14 |
| 2021-03-31 | $-14 |
| 2020-12-31 | $-17 |
| 2020-09-30 | $-16 |
| 2020-06-30 | $-18 |
| 2020-03-31 | $-24 |
| 2019-12-31 | $-23 |
| 2019-09-30 | $-29 |
| 2019-06-30 | $-31 |
| 2019-03-31 | $-34 |
| 2018-12-31 | $-21 |
| 2018-09-30 | $-30 |
| 2018-06-30 | $-28 |
| 2018-03-31 | $-27 |
| 2017-12-31 | $-21 |
| 2017-09-30 | $-20 |
| 2017-06-30 | $-16 |
| 2017-03-31 | $-26 |
| 2016-12-31 | $-25 |
| 2016-09-30 | $-23 |
| 2016-06-30 | $-29 |
| 2016-03-31 | $-30 |
| 2015-12-31 | $-20 |
| 2015-09-30 | $-23 |
| 2015-06-30 | $-16 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $11 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-10 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $5 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-5 |
| 2011-12-31 | $6 |
| 2011-09-30 | $-5 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $-2 |
| 2010-06-30 | $-2 |
| 2010-03-31 | $-1 |
| 2009-12-31 | $-2 |
| 2009-09-30 | $-3 |
| 2009-06-30 | $-7 |
| 2009-03-31 | $-8 |
